Researchers at the University of Pittsburgh say a new minimally invasive intervention can target the root cause of neural function loss.
L.S. Starrett Co. named Roger Amrol as CEO, Barry Laughlin as COO, Allen Look as CIO and Jon-Michael Raymond as CRO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback